Thrombocytopenic purpura with depot medroxyprogesterone acetate and subsequent use of contraceptive implant: making decisions in the absence of evidence
| Autor: | Gillian Stephen, Ruth Holman |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Adult
medicine.medical_specialty medicine.medical_treatment Population Decision Making Medroxyprogesterone Acetate Risk Factors medicine Contraceptive Agents Female Medroxyprogesterone acetate Humans education reproductive and urinary physiology Gynecology Drug Implants education.field_of_study Desogestrel Progestogen Obstetrics business.industry Depo provera Obstetrics and Gynecology General Medicine medicine.disease Thrombocytopenic purpura Contraceptives Oral Synthetic Reproductive Medicine Purpura Thrombocytopenic Family planning Family Planning Services Female Contraceptive implant business Developed country hormones hormone substitutes and hormone antagonists medicine.drug |
| Zdroj: | The journal of family planning and reproductive health care. 31(4) |
| ISSN: | 1471-1893 |
| Popis: | This article presents the case study of a 19-year-old women developing thrombocytopenic purpura after receiving her first injection of DMPA at a family planning clinic. Two months after receiving DMPA the patients platelet count remained low. She returned to the clinic to discuss her contraceptive options. There was concern that other progestogens might have a similar effect however after counselling the patient chose Implanon. This case report suggest that it is possible to use an alternative progestogen after a suspected drug-induced thrombocytopenia to an injectable progestogen. (excerpt) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|